title: [Development of the human adrenal glands].
abstract: The human adrenal is an endocrine gland located at the superior part of the kidney. Composed of the adrenal cortex of mesoblastic origin and the adrenal medulla of neuroectoblastic origin, the human fetal adrenal grows considerably during the first three months of development. From 12 to 18 weeks of development (WD), the weight of the adrenals increases seven-fold. The gland's weight doubles from 18 to 28 WD and from 28 to 36 WD. At birth, the two adrenals weigh on average 10 g. At the 8th week, two zones are individualized in the adrenal cortex: the definitive zone and the fetal inner zone. At the second trimester, according to ultrastructural and biochemical studies, a third zone, called the transition zone, is individualized between the definitive zone and the fetal inner zone. The definitive zone persists, but the origin of the three zones (glomerular, fascicular and reticular) of adult adrenal cortex is not known. The fetal inner zone regresses from the 5th month of gestation and disappears totally one year after birth. At the 8th week, the immature neuroblasts migrate to the definitive zone, then to the fetal inner zone to compose the adrenal medulla, which develops essentially after birth and during the first year. Before the 10th week, the human fetal adrenal is able to produce steroid hormones, in particular dehydroepiandrosterone sulfate (DHEA-S); the secretion of cortisol remains discussed. The development of the human fetal adrenal is complex and is under the control of hormones (ACTH, LH and betaHCG), growth factors (ACTH essentially) and transcription factors (essentially SF1 and DAX-1). Knowledge of morphological and molecular phenomena of this development permits to understand the pathophisiology of congenital adrenal deficiencies.
authors.affiliation: Laboratoire d'Histologie et Embryologie moléculaires, Faculté de Médecine Lyon-RTH Laennec, rue Guillaume Paradin, 69372 Lyon Cedex 08, France.
authors.forename: K
authors.initials: K
authors.lastname: Folligan
authors.forename: R
authors.initials: R
authors.lastname: Bouvier
authors.forename: F
authors.initials: F
authors.lastname: Targe
authors.forename: Y
authors.initials: Y
authors.lastname: Morel
authors.forename: J
authors.initials: J
authors.lastname: Trouillas
mesh_terms: D000302:Adrenal Cortex / Q000196:embryology / Q000254:growth & development; D000305:Adrenal Cortex Hormones / Q000096:biosynthesis / Q000378:metabolism; D000311:Adrenal Glands / Q000196:embryology / Q000254:growth & development*; D000309:Adrenal Insufficiency / Q000209:etiology / Q000235:genetics; D000313:Adrenal Medulla / Q000196:embryology / Q000254:growth & development; D000324:Adrenocorticotropic Hormone / Q000502:physiology; D002454:Cell Differentiation; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000502:physiology; D005823:Genetics; D005865:Gestational Age; D006801:Humans; D007986:Luteinizing Hormone / Q000502:physiology; D009929:Organ Size
chemical_list: D000305:Adrenal Cortex Hormones; D018997:Chorionic Gonadotropin, beta Subunit, Human; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone